Mark Horowitz

The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs

Authored by Mark Horowitz, and David M. Taylor, the world’s first antidepressants deprescribing guidelines for psychiatry are now available. The publishers say: “Comprehensive resource describing guidelines for safely reducing or stopping (deprescribing) antidepressants, benzodiazepines, gabapentinoids and z-drugs for patients, including step-by-step guidance…
Read more

Antidepressant withdrawal should be taken seriously – we’re investigating ways to help people come off the pills

This article from Mark Horowitz, Joanna Moncrieff and Katharine Wallis has been published by The Conversation. It begins: “Misinformation about antidepressants  is rife  and is probably fuelling their rise in use. Chief among these false ideas are: Antidepressant withdrawal effects are mild and…
Read more

Acceptability and optimisation of resources to support antidepressant cessation: A qualitative think-aloud study with patients

This study by Suzanne McDonald, Katharine Ann Wallis, Mark Horowitz, Esther Mann, Vilany Le and Maria Donald has been published in the British Journal of General Practice. The abstract says: “Background: Stopping long-term (>12 months) antidepressants can be difficult for patients…
Read more

Response to Criticism of Our Serotonin Paper

This article by Joanna Moncrieff and Mark Horowitz has been published by Mad in America. It begins: “We recently published a  paper  finding that the serotonin hypothesis of depression (the idea that depression is caused by low serotonin or reduced serotonin activity)…
Read more

Services for People Withdrawing From Antidepressants

“New study documents what antidepressant users need to help them come off safely.” Key Points: One in four people will experience severe withdrawal symptoms when trying to reduce or come off antidepressants. There are no specialized services to support people…
Read more

After skool: Mark Horowitz – common misconceptions about depression & antidepressants

Dr. Mark Horowitz is a training psychiatrist and Clinical Research Fellow in Psychiatry at North East London NHS Foundation Trust. He has a doctorate in the neurobiology of depression and the action of antidepressants from the Institute of Psychiatry, Psychology and Neuroscience at King’s…
Read more

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

This article – from Mark Abie Horowitz, Adele Framer, Michael P. Hengartner, Anders Sørensen & David Taylor – has been published in the journal CNS Drugs. The abstract says: “Adaptation of the brain to the presence of a drug predicts withdrawal…
Read more

Antidepressants Work Better Than Sugar Pills Only 15 Percent of the Time

This article by Adam Piore has been published in Newsweek magazine. It begins: “Five years ago Mark Horowitz seemed an unlikely skeptic of psycho-pharmaceuticals. He had been taking the popular antidepressant Lexapro virtually every day for 15 years. He was so…
Read more

Follow

Get the latest posts delivered to your mailbox:

Your email address will not be passed to any other organisation. It will only be used to send you new posts made on this website.

MENU